Search clinical trials for: bDMARDs

Total 10 results

Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs (TARA)

Rheumatoid Arthritis

China
Taipei Veterans General Hospital, Taiwan

Not yet recruiting

The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs

Inflammatory Arthritis | HBV
Universidade Nova de Lisboa
Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar Lisboa Ocidental... and other collaborators

Recruiting

The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA (MicroSpA & RA)

Arthritis, Rheumatoid | Axial Spondyloarthritis

Portugal
University Hospital Bispebjerg and Frederiksberg

Active, not recruiting

Assessing Pain by the painDETECT Questionnaire (PDQ)

Rheumatoid Arthritis | Spondylarthropathies | Inflammatory Arthritis | Psoriatic Arthritis
Societe Francaise de Rhumatologie
Assistance Publique - Hôpitaux de Paris; University Hospital, Toulouse

Completed

Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART Registry

Rheumatoid Arthritis

France
Gilead Sciences

Withdrawn

Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment

Rheumatoid Arthritis
Nordic Pharma SAS

Active, not recruiting

Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis (STRATEGE2)

Rheumatoid Arthritis | Psoriatic Arthritis

France
Dr Ornella Conort

Completed

Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis. (SPADHESION)

Treatment Adherence | Spondyloarthritis

France
Centre Hospitalier Universitaire de Saint Etienne
Pfizer

Completed

Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy

Rheumatoid Arthritis

France
Bristol-Myers Squibb

Completed

Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)

Rheumatoid Arthritis

3

Subscribe